Research study Program year 2025 Source: CMS Open Payments

Safety, tolerability and pharmacodynamics of BI 770371 administered intravenously in patients with compensated cirrhosis due to MASH: a Phase IIa, multi-center, randomized, double-blind, placebo-controlled trial

Research payments

$1,848,604

998 payments

Through program year 2025, $1,848,604 in research payments was reported against Safety, tolerability and pharmacodynamics of BI 770371 administered intravenously in patients with compensated cirrhosis due to MASH: a Phase IIa, multi-center, randomized, double-blind, placebo-controlled trial, across 998 payments, paid by Boehringer Ingelheim International GmbH.

Paid by: Boehringer Ingelheim International GmbH
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$1,848,604	998

Breakdown

Who paid Research payments · program year 2025

Boehringer Ingelheim International GmbH $1,848,604 998 payments

Who received the money Research payments · program year 2025

Evolution Clinical Trials Organisation paid for research $468,483 177 payments
Texas Liver Institute Ste 101 Organisation paid for research $393,303 208 payments
The Institute For Liver Health II LLC Organisation paid for research $176,774 110 payments
The Liver Institute At Methodist Dallas Organisation paid for research $164,363 132 payments
Blessed Healthcare Organisation paid for research $149,159 71 payments
Progressive Medical Research Organisation paid for research $129,809 62 payments
Southern California Research Center Organisation paid for research $111,504 74 payments
Future Innovative Treatments LLC Organisation paid for research $110,904 64 payments
Catalina Research Institute LLC Organisation paid for research $69,171 43 payments
Houston Research Institute Organisation paid for research $32,312 19 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.